Cardiff Oncology Inc. (CRDF)
NASDAQ · Healthcare
Cardiff Oncology Inc. Net Income 2011–2025
Cardiff Oncology Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cardiff Oncology Inc. net income for the quarter ending March 31, 2026 was -12.3 M, a 8.11% decrease year-over-year.
- Cardiff Oncology Inc. net income for the twelve months ending March 31, 2026 was -51.0 M, a 17.53% increase year-over-year.
- Cardiff Oncology Inc. annual net income for 2025 was -45.9 M, a 0.92% increase from 2024.
- Cardiff Oncology Inc. annual net income for 2024 was -45.4 M, a 9.63% increase from 2023.
- Cardiff Oncology Inc. annual net income for 2023 was -41.4 M, a 7.07% increase from 2022.
- Cardiff Oncology Inc. annual net income for 2022 was -38.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cardiff Oncology Inc. Net Income — FAQ
Cardiff Oncology Inc. (CRDF) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Cardiff Oncology Inc.'s net income?
Cardiff Oncology Inc. (CRDF) reported net income of -$46M for fiscal 2025.
Where can I see CRDF's net income history?
The chart and table above show Cardiff Oncology Inc.'s net income by year and by quarter, including the growth rate.